US Patent Issued to Bristol-Myers Squibb on Sept. 2 for "System for interrogating serially-connected drug modules in a combinatorial drug delivery device" (Maryland, New Jersey Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,403,254, issued on Sept. 2, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"System for interrogating serially-connected drug modules in a combinatorial drug delivery device" was invented by Martin John McLoughlin (Hillsborough, N.J.) and Jeffrey Manfred Gunnarsson (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "In one aspect, a combinatorial drug delivery device is provided herein including: a plurality of serially connectable modules, each including at least one drug component; and, a master controller having a computing processing unit. Each of the modules includes: a non-transitory memory having stored therein an address and an...